Pre-Diagnostic Circulating Resistin Concentrations Are Not Associated with Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition Study.

colorectal cancer inflammation pre-diagnostic resistin prospective risk

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
09 Nov 2022
Historique:
received: 20 09 2022
revised: 31 10 2022
accepted: 01 11 2022
entrez: 26 11 2022
pubmed: 27 11 2022
medline: 27 11 2022
Statut: epublish

Résumé

Resistin is a polypeptide implicated in inflammatory processes, and as such could be linked to colorectal carcinogenesis. In case-control studies, higher resistin levels have been found in colorectal cancer (CRC) patients compared to healthy individuals. However, evidence for the association between pre-diagnostic resistin and CRC risk is scarce. We investigated pre-diagnostic resistin concentrations and CRC risk within the European Prospective Investigation into Cancer and Nutrition using a nested case-control study among 1293 incident CRC-diagnosed cases and 1293 incidence density-matched controls. Conditional logistic regression models controlled for matching factors (age, sex, study center, fasting status, and women-related factors in women) and potential confounders (education, dietary and lifestyle factors, body mass index (BMI), BMI-adjusted waist circumference residuals) were used to estimate relative risks (RRs) and 95% confidence intervals (CIs) for CRC. Higher circulating resistin concentrations were not associated with CRC (RR per doubling resistin, 1.11; 95% CI 0.94-1.30;

Identifiants

pubmed: 36428592
pii: cancers14225499
doi: 10.3390/cancers14225499
pmc: PMC9688251
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Cancer Causes Control. 2014 Oct;25(10):1397-405
pubmed: 25053407
J Immunol. 2005 May 1;174(9):5789-95
pubmed: 15843582
Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1291-3
pubmed: 17548700
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Cancer. 2001 Feb 15;91(4):854-62
pubmed: 11241255
World J Gastroenterol. 2010 Mar 14;16(10):1252-7
pubmed: 20222170
Gut. 2017 Apr;66(4):683-691
pubmed: 26818619
Biochem Biophys Res Commun. 2003 Jan 10;300(2):472-6
pubmed: 12504108
Biometrics. 1988 Dec;44(4):1157-68
pubmed: 3233252
World J Gastroenterol. 2014 Jun 28;20(24):7941-9
pubmed: 24976730
J Clin Endocrinol Metab. 2003 Nov;88(11):5452-5
pubmed: 14602788
Metab Syndr Relat Disord. 2011 Jun;9(3):203-10
pubmed: 21332410
Front Physiol. 2019 Nov 19;10:1399
pubmed: 31803062
Clin Chim Acta. 2015 Jan 1;438:46-54
pubmed: 25128719
Am J Epidemiol. 2012 Apr 1;175(7):653-63
pubmed: 22422922
EPMA J. 2019 Jul 20;10(3):307-316
pubmed: 31462946
Metabolism. 2019 Mar;92:61-70
pubmed: 30586573
Carcinogenesis. 2012 Jun;33(6):1211-8
pubmed: 22431719
Am J Epidemiol. 1998 Mar 15;147(6):556-62
pubmed: 9521182
Cancer Res. 2012 Oct 15;72(20):5328-37
pubmed: 22926557
Public Health Nutr. 2002 Dec;5(6B):1147-62
pubmed: 12639224
Clin Chem Lab Med. 2007;45(7):899-902
pubmed: 17617035
Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3108-15
pubmed: 18990751
Clin Chim Acta. 2012 Apr 11;413(7-8):760-4
pubmed: 22296675
Cancer Sci. 2010 May;101(5):1286-91
pubmed: 20331631
Atherosclerosis. 2017 Apr;259:51-59
pubmed: 28286252
J Clin Endocrinol Metab. 2008 Jul;93(7):2647-53
pubmed: 18460562
PLoS Med. 2004 Nov;1(2):e45
pubmed: 15578112
Int J Cancer. 2007 Jul 15;121(2):368-76
pubmed: 17372899
Biomed Res Int. 2016;2016:7367485
pubmed: 27642602
Eur J Endocrinol. 2010 Feb;162(2):281-8
pubmed: 19920090
Am J Clin Nutr. 2008 Nov;88(5):1213-24
pubmed: 18996855
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
Am J Epidemiol. 2010 Aug 15;172(4):407-18
pubmed: 20634278
Eur Rev Med Pharmacol Sci. 2005 May-Jun;9(3):161-5
pubmed: 16080635
J Clin Endocrinol Metab. 2003 Oct;88(10):4848-56
pubmed: 14557464
Public Health Nutr. 2003 Jun;6(4):407-13
pubmed: 12795830
Clin Immunol. 2009 Nov;133(2):157-70
pubmed: 19740705
J Nutr. 2020 Apr 1;150(4):663-671
pubmed: 31758189
Cancer Invest. 2008 Dec;26(10):1008-14
pubmed: 18798067
Cancer Res. 2012 Jun 15;72(12):3029-37
pubmed: 22511581
Cancers (Basel). 2021 Apr 22;13(9):
pubmed: 33922197
Curr Opin HIV AIDS. 2010 Nov;5(6):473-9
pubmed: 20978390
Obes Facts. 2019;12(6):590-605
pubmed: 31698359
Diabetes. 2001 Oct;50(10):2199-202
pubmed: 11574398
Nature. 2001 Jan 18;409(6818):307-12
pubmed: 11201732

Auteurs

Thu-Thi Pham (TT)

Molecular Epidemiology Research Group, Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany.
Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.

Katharina Nimptsch (K)

Molecular Epidemiology Research Group, Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany.

Krasimira Aleksandrova (K)

Department of Epidemiological Methods and Etiological Research, Leibniz Institute for Prevention Research and Epidemiology-BIPS, 28359 Bremen, Germany.
Faculty of Human and Health Sciences, University of Bremen, 28359 Bremen, Germany.

Mazda Jenab (M)

Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), World Health Organization, 150 Cours Albert Thomas, CEDEX 08, 69372 Lyon, France.

Robin Reichmann (R)

Department of Epidemiological Methods and Etiological Research, Leibniz Institute for Prevention Research and Epidemiology-BIPS, 28359 Bremen, Germany.

Kana Wu (K)

Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.

Anne Tjønneland (A)

Danish Cancer Society Research Center, 2100 Copenhagen, Denmark.
Department of Public Health, University of Copenhagen, DK-1353 Copenhagen, Denmark.

Cecilie Kyrø (C)

Danish Cancer Society Research Center, 2100 Copenhagen, Denmark.

Matthias B Schulze (MB)

Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, 14558 Nuthetal, Germany.
Institute of Nutritional Science, University of Potsdam, 14558 Nuthetal, Germany.

Rudolf Kaaks (R)

Department of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Verena Katzke (V)

Department of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Domenico Palli (D)

Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), 50139 Florence, Italy.

Fabrizio Pasanisi (F)

Dipartimento di Medicina Clinica E Chirurgia, Federico Ii University, 80131 Naples, Italy.

Fulvio Ricceri (F)

Centre for Biostatistics, Epidemiology, and Public Health (C-BEPH), Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.
Unit of Epidemiology, Regional Health Service ASL TO3, 10095 Grugliasco, Italy.

Rosario Tumino (R)

Hyblean Association for Epidemiological Research, AIRE ONLUS, 97100 Ragusa, Italy.

Vittorio Krogh (V)

Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Venezian 1, 20133 Milan, Italy.

Jeanine Roodhart (J)

Department of Medical Oncology, UMC Utrecht, 3584 CX Utrecht, The Netherlands.

Jesús Castilla (J)

Navarra Public Health Institute-IdiSNA, 31003 Pamplona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.

Maria-Jose Sánchez (MJ)

CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.
Escuela Andaluza de Salud Pública (EASP), 18011 Granada, Spain.
Instituto de Investigación Biosanitaria ibs.GRANADA, 18012 Granada, Spain.
Department of Preventive Medicine and Public Health, University of Granada, 18071 Granada, Spain.

Sandra Milena Colorado-Yohar (SM)

CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.
Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, 30008 Murcia, Spain.
Research Group on Demography and Health, National Faculty of Public Health, University of Antioquia, Medellín 050010, Colombia.

Justin Harbs (J)

Department of Radiation Sciences, Oncology, Umeå University, SE-901 87 Umeå, Sweden.

Martin Rutegård (M)

Department of Surgical and Perioperative Sciences, Surgery, Umeå University, SE-901 87 Umeå, Sweden.
Wallenberg Centre for Molecular Medicine, Umeå University, SE-901 87 Umeå, Sweden.

Keren Papier (K)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK.

Elom K Aglago (EK)

Department of Epidemiology and Biostatistics, Imperial College London, London W2 1PG, UK.

Niki Dimou (N)

Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), World Health Organization, 150 Cours Albert Thomas, CEDEX 08, 69372 Lyon, France.

Ana-Lucia Mayen-Chacon (AL)

Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), World Health Organization, 150 Cours Albert Thomas, CEDEX 08, 69372 Lyon, France.

Elisabete Weiderpass (E)

International Agency for Research on Cancer, World Health Organization, 69372 Lyon, France.

Tobias Pischon (T)

Molecular Epidemiology Research Group, Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany.
Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.
Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Biobank Technology Platform, 13125 Berlin, Germany.
Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Core Facility Biobank, 13125 Berlin, Germany.

Classifications MeSH